Skip to main content
Canna~Fangled Abstracts

Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1

By May 8, 2023No Comments

. 2023 May 5;13(1):7376.

doi: 10.1038/s41598-023-32927-4.

Adriana Yndart Arias 1 2, Nagesh Kolishetti 3 4, Arti Vashist 3 4, Lakshmana Madepalli 3 4, Lorgeleys Llaguno 3, Madhavan Nair 5 6
Affiliations 

Free article

Abstract

Human immunodeficiency virus (HIV) infection is associated with a chronic inflammatory stage and continuous activation of inflammasome pathway. We studied the anti-inflammatory effects of the compound cannabidiol (CBD) in comparison with Δ (9)-tetrahydrocannabinol [Δ(9)-THC] in human microglial cells (HC69.5) infected with HIV. Our results showed that CBD reduced the production of various inflammatory cytokines and chemokines such as MIF, SERPIN E1, IL-6, IL-8, GM-CSF, MCP-1, CXCL1, CXCL10, and IL-1 β compared to Δ(9)-THC treatment. In addition, CBD led to the deactivation of caspase 1, reduced NLRP3 gene expression which play a crucial role in the inflammasome cascade. Furthermore, CBD significantly reduced the expression of HIV. Our study demonstrated that CBD has anti-inflammatory properties and exhibits significant therapeutic potential against HIV-1 infections and neuroinflammation.

Similar articles

See all similar articles

References

    1. Hanus, L. O. et al. Phytocannabinoids: A unified critical inventory. Nat. Prod. Rep. 33(12), 1357–1392 (2016). – PubMed – DOI
    1. McPartland, J. M., Glass, M. & Pertwee, R. G. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: Interspecies differences. Br. J. Pharmacol. 152(5), 583–593 (2007). – PubMed – PMC – DOI
    1. Mechoulam, R., Parker, L. A. & Gallily, R. Cannabidiol: An overview of some pharmacological aspects. J. Clin. Pharmacol. 42(S1), 11S-19S (2002). – PubMed – DOI
    1. Bisogno, T. et al. Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol. 134(4), 845–852 (2001). – PubMed – PMC – DOI
    1. Bhunia, S., Kolishetti, N., Arias, A. Y., Vashist, A. & Nair, M. Cannabidiol for neurodegenerative disorders: A comprehensive review. Front Pharmacol. 13, 989717. https://doi.org/10.3389/fphar.2022.989717 (2022). – DOI – PubMed – PMC

LinkOut – more resources

 

Leave a Reply